Diagnostic The primary use for poligeenan is for clinical diagnostic applications, and specifically the suspension of
barium sulfate slurries used in
X-ray studies of the mouth, throat, and
esophagus during swallowing. For this application, poligeenan delivers three essential properties: First, its viscosity imparts lubricity to make the slurry easier to swallow. Second, this same viscosity is high enough to maintain full suspension of all barium sulfate particles during the complete X-ray procedure. Third, the high charge density of the poligeenan solution (ester sulfate units) prevents caking or aggregation of the barium sulfate particles during long-term storage of ready-to-use slurry products, these being easily reconstituted by shaking. The combination of these three application properties necessitates poligeenan to have molecular weights in the range 10-20 kDa.
Experimental research In 1969, Adrian Julian Marcus and James Watt demonstrated that poligeenan could induce gastrointestinal lesions in
animal models, which was followed by decades of
medical research using the substance to study
inflammatory bowel disease. Unlike poligeenan, carrageenan is an approved food additive with an extensive
toxicology data base that has been reviewed by regulatory bodies and provides scientific evidence for safe inclusion in foods. == Production ==